Table 1.

Baseline Characteristics of Study Participants

Characteristics	n (%) or mean ± SD (n=4110)
Age in years	52 ± 9.4
Female sex	1528 (37.2)
Nonwhite race	998 (24.5)
Country
Brazil	612 (14.9)
Canada	498 (12.1)
United States	3000 (73.0)
Graft vintage in years	5 ± 5.0
History of CVD	820 (20.0)
History of diabetes mellitus	1663 (40.5)
Hypertension	3778 (92.0)
Body mass index (kg/m2)	29 ± 6.2
Current Smoker	451 (11.1)
Baseline creatinine (μmol/L)	1.7 ± 0.6
Baseline eGFR (mL/min per 1.73 m2)	48.9 ± 17.7
Baseline CKD Stage
Stage 1 (eGFR 90 mL/min per 1.73 m2)	115 (2.9)
Stage 2 (eGFR 60-89 mL/min per 1.73 m2)	822 (20.4)
Stage 3 (eGFR 30-59 mL/min per 1.73 m2)	2571 (63.9)
Stage 4 (eGFR 15-29 mL/min per 1.73 m2)	507 (12.6)
Stage 5 (eGFR <15 mL/min per 1.73 m2)	10 (0.3)

Abbreviations: CVD = Cardiovascular Disease